SK bioscience Co.,Ltd. (KRX:302440)
South Korea flag South Korea · Delayed Price · Currency is KRW
39,100
-50 (-0.13%)
Apr 18, 2025, 3:30 PM KST

SK bioscience Revenue

In the year 2024, SK bioscience had annual revenue of 267.55B KRW, down -27.59%. SK bioscience had revenue of 156.85B in the quarter ending December 31, 2024, with 73.11% growth.

Revenue
267.55B
Revenue Growth
-27.59%
P/S Ratio
11.45
Revenue / Employee
271.90M
Employees
984
Market Cap
3,063.38B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024267.55B-101.96B-27.59%
Dec 31, 2023369.51B-87.22B-19.10%
Dec 31, 2022456.73B-472.28B-50.84%
Dec 31, 2021929.00B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition